Articles On Telix Pharmaceuticals (ASX:TLX)

Telix Pharmaceuticals Ltd (ASX: TLX) shares are all over the place. The ASX biotech stock is down 5% over the past five trading days, yet up 16% over the past month and 27% year to date. Zoom out further and the picture flips again. Teli...

Finding ASX shares that can genuinely scale over time is not always easy. A lot of companies talk about big opportunities, but only a handful actually build the foundations needed to turn that potential into long-term growth.  I th...

A gaggle of drug developers is due to disclose company-making clinical study results this year While late-stage clinical trial victory does not confer commercial success, the results tend to be ‘do or die’ In the main, share valuations don...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are in the red in Tuesday lunchtime trade. At the time of writing the shares are down 1.7% to $14.50. Despite today's decline, the ASX biopharmaceutical company's shares have rebounded a whoppi...

Investors often target blue-chip ASX 200 shares for lower volatility and consistent earnings.  It's often assumed that because these companies are well-established, there is limited upside.  However, here are some blue-chip stocks th...

Telix Pharmaceuticals has lodged a cleansing notice with the ASX regarding its recently announced US$600 million convertible bond offering, a regulatory filing that clears the way for future share issuance without requiring a prospectus. Th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Australian biotechs are successfully turning promising science into a scalable, repe...

Highlights Short interest highlights shifting market sentiment Multiple ASX 200 names dominate the list Sector-wide concerns driving cautious positioning High short interest across ASX 200 stocks highlights cautious market sentime...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

ASX health sector up 0.16% for the past five days while broader market rises 0.39% Pro Medicus signs $37 million renewal contract with US-based North Western Medicine  Consortium comprising Genesis Capital Investment Management and Washing...

Now could be a good time to buy Telix Pharmaceuticals Ltd (ASX: TLX) shares. That's the view of analysts at Bell Potter, who are tipping the radiopharmaceuticals company as a top buy this week. What is the broker saying? Bell Potter notes t...

Highlights Market rises on renewed US-Iran diplomacy optimism Tech stocks lead gains for second straight session Energy sector lags as oil prices ease ASX 200 opened higher on global optimism, with tech stocks leading gains while...

The S&P/ASX 200 Index (ASX: XJO) is having a relatively positive session on Wednesday. In afternoon trade, the benchmark index is up 0.1% to 8,982 points. Four ASX shares that have failed to follow the market higher today are listed b...

ASX consumer discretionary stocks have been largely underperforming in 2026. Rising interest rates, inflation and subdued consumer confidence have all weighed heavily on investor sentiment.  When economic headwinds like these hit at o...

Orthocell shares soar 20% after the go-ahead to sell flagship Remplir product to US defence and vet affairs hospitals Telix seals monster $840 million debt capital raising Forget Lego – Genetic Signatures finds its own Danish building bloc...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are on the move on Wednesday morning. At the time of writing, the ASX radiopharmaceuticals stock is down 7.5% to $14.28. As a comparison, the ASX 200 index is trading 0.25% higher in morning trade...

The Virgin Australia Holdings Ltd (ASX: VGN) share price is in focus after the airline confirmed its FY26 financial guidance remains unchanged, with underlying EBIT and EBIT margin expected to improve in 2HFY26 despite a surge in fuel price...

The National Storage REIT (ASX: NSR) share price is in focus as investors digest news of the proposed $2.80-per-security cash offer from a Brookfield and GIC consortium, valuing the group at over $4 billion. Security holders who held NSR se...

The Evolution Mining Ltd (ASX: EVN) share price is in focus as the company moved to a net cash position in the March 2026 quarter, generating $406 million in group cash flow and maintaining strong operational delivery. Record quarterly net...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 /PRNewswire/ – Telix Pharma...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company successfully priced and increased its US$600 million convertible bond offering, up from US$550 million due to strong global investor demand. What did T...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and Indianapolis, April 15, 2026 /PRNewswire/ — Telix Pharma...

The Yancoal Australia Ltd (ASX: YAL) share price is in focus today following news that the company will acquire an 80% interest in the Kestrel Coal Mine, a large-scale, long-life metallurgical coal asset based in Queensland's Bowen Basin. K...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company released an investor presentation, revealing strong top-line growth in 2025. Group revenue jumping 56% year-on-year to US$804 million, and underlying p...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was on form and pushed higher. The benchmark index rose 0.5% to 8,970.8 points. Will the market be able to build on this on Wednesday? Here are five things to watch: ASX 200 to rise again T...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ — Telix...

Highlights Energy sector gains strength on oil supply concerns Tech and gold stocks weaken amid rising yields Company updates trigger sharp stock-specific moves The Australian market ended on a softer note as global te...

The S&P/ASX 200 Index (ASX: XJO) is having a reasonably poor start to the week. In afternoon trade, the benchmark index is down 0.45% to 8,921.3 points. Four ASX shares that are not letting that hold them back today are listed below. He...

Highlight Futures point to a softer start for the ASX 200 Oil surges as Strait of Hormuz tensions escalate Global markets turn cautious after last week’s rebound ASX 200 is set to open lower as Middle East tensions escalate, push...

Telix shares surge up to 9% after this morning’s surprise deal with Regeneron Relating to therapies not yet being developed by Telix, the compact includes a US$40 million upfront payment Oh baby! Genesis returns with improved Monash IVF o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is charging higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed on Friday trading for $14.64. In early morning trade on Monda...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price rose more than 5% after announcing a Regeneron partnership. Telix Pharmaceuticals is a global biopharmaceutical business that’s looking to develop and sell radiopharmaceuticals to address...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The Insignia Financial Ltd (ASX: IFL) share price is in focus as shareholders today considered a proposed $4.80 per share, all-cash acquisition by CC Capital Partners, representing a 56.9% premium to the last closing price. What did Insigni...

S&P/ASX 200 Index (ASX: XJO) blue-chip shares could be a smart choice during this volatile, uncertain period. Stability and strength may be a winning combination over the rest of 2026. There are some businesses that may well see thei...

The GQG Partners Inc (ASX: GQG) share price is in focus after the fund manager reported total funds under management (FUM) of US$162.5 billion as of 31 March 2026, reflecting net outflows of US$8.6 billion in the first quarter, partially of...

The Pro Medicus Ltd (ASX: PME) share price is in focus today after the company secured a five-year, $37 million contract renewal with Northwestern Medicine, featuring increased minimum spend and higher fees per transaction. What did Pro Med...

The Champion Iron Ltd (ASX: CIA) share price is in focus today as the company announced the successful completion of its voluntary cash tender offer to acquire over 92% of Norway's Rana Gruber, a high-purity iron ore producer. Champion paid...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company announced a major collaboration with US-based Regeneron Pharmaceuticals, highlighted by a US$40 million upfront payment and the development of next-gen...

The Brambles Ltd (ASX: BXB) share price is in focus today after the logistics company received a judgment in its long-running shareholder class action. The Federal Court upheld some claims regarding Underlying Profit and revenue growth disc...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Telix and Regeneron to co-develop and co-commercialize next-generation radiophar...

The a2 Milk Company Ltd (ASX: A2M) share price is in focus after releasing a trading and outlook update, highlighting strong demand for its infant milk formula (IMF) in China and ongoing supply chain challenges. What did The a2 Milk Company...

Most Australians wait until around age 65 to retire. At this point you can access your superannuation, and you're just two years away (if you're eligible) from receiving your Age Pension payment. But did you know that you can retire a fe...

On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week with a small decline. The benchmark index fell 0.15% to 8,960.6 points. Will the market be able to bounce back on Monday? Here are five things to watch: ASX 200 expected to...

Highlights Market posts strongest weekly momentum in recent times Sector rotation shapes shifting investor sentiment Global cues keep outlook uncertain yet active The Australian market delivered a strong weekly perform...

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre. In this segment, we wrap up the stocks and company announcements you were watching this week on Australia’s #1 finance website. Let’s get straight into...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. The benchmark index is currently down 0.4% to 8,938 points. Four ASX shares that are not letting that hold them back are listed below. H...

Telix Pharmaceuticals Ltd (ASX: TLX), Magellan Financial Group Ltd (ASX: MFG), and Fortescue Ltd (ASX: FMG) shares are grabbing financial news headlines today. Heading into the Friday lunch hour, two of the S&P/ASX 200 Index (ASX: XJO)...